Frederick Abbott

WHO INB related interactive dialogues, Topic 1. Article 12 (Pathogen Access and Benefit-Sharing System), with submission of written response to discussion questions proposed by the Bureau for resource persons

WHO Technical Advisory Group (TAG) on Local Product and Technology Transfer (LPTT), Responding to the Declaration of a Public Health Emergency of International Concern (PHEIC) regarding Mpox (Virtual)

The State of Intellectual Property and International Law, in New Trends in International Law: Festscrift in Honor of Judge Hisashi Owada, edited by Chia-Jui Cheng, Brill | Nijhoff 2024

Presentation and discussion of Global Health Law Committee of International Law Association 2024 Report at Athens Biennial

Bridging Innovations: Technology Transfer for Sustainable Local Production, The Road to World Local Production Forum 2025, World Health Organization, AIM Congress 2024 (Adapting To A Shifting Investment Landscape: Harnessing New Potential For Global Economic Development), Abu Dhabi

Innovation and access to medicines, and New directions in TRIPS implementation, Symposium on Policy insights and practical lessons from TRIPS implementation, WTO Headquarters, Geneva

High-Level Dialogue: TRIPS at 30, WTO Headquarters, Geneva

Reflections on the LDC Experience with Article 66.2 of the WTO TRIPS Agreement: Prospects for the Future, and Moderator, Workshop on the Implementation of Article 66.2 of the TRIPS Agreement: Incentives for Technology Transfer to LDCs, WTO Headquarters, Geneva 

Panelist (conversation with) on Supporting Technology Transfers through Policies and Policy Coherence (moderated by Dr. Jicui Dong), WHO-AfricaCDC meeting on Facilitating Technology Transfer to Promote Local Manufacturing and Access to Vaccines, Medicines, and Other Health Technologies in Africa, Gaborone, Botswana

Chair Meeting of WHO Technical Advisory Group (TAG) - Local Production and Technology Transfer, WHO Headquarters, Geneva

Submission of Global Health Law Committee draft Report for the ILA 2024 Athens Biennial (updated to June 19, 2024 version)

Publication of Frederick M. Abbott, Thomas Cottier, Francis Gurry, Ryan B. Abbott, Mira Burri, Henning Grosse Ruse-Khan and Maegan McCann, International Intellectual Property in an Integrated World Economy, Fifth Edition (Aspen Publishing 2024)

Nominated for Best Academic Article, 2024 Antitrust Writing Awards, Unilateral Conduct subcategory, Prosecuting Excessive Pricing of Pharmaceuticals under Competition Law: Evolutionary Development, 24 Columbia Science & Technology Law Review 173 (2023),  https://awards.concurrences.com/en/awards/2024/academic-articles/prosecuting-excessive-pricing-of-pharmaceuticals-under-competition-law, (voting open)

Presentation Intellectual Property and Technology Transfer for COVID-19 Vaccines: Assessment of the Record, AVPA-AVMI Private Sector Workshop on Technology Transfer (Online/Africa)

session on Geo-diversifying manufacturing capacity through licensing and technology transfer, 2nd World Local Production Forum (WHO), Hague, Netherlands (Nov. 6-8, 2023) 

Publication of Frederick Abbott, Intellectual Property and Technology Transfer for COVID-19 Vaccines: Assessment of the Record, World Intellectual Property Organization, 2023 (Geneva, Switzerland)

Workshop with South Africa Competition Commission staff on Intellectual Property Law in Pharmaceuticals, remote (US-South Africa)

TRIPS and public health: the challenge of coordination of policy at international, regional and national levels, and; TRIPS and competition policy: reflections on the international dimension, TRIPS at 25, World Trade Organization, Geneva

Plenary Session, Challenges and Opportunities for IP Research in a Knowledge and Post-Pandemic Economy; Chair panel and moderator, Sustainable Development, 3D Printing and Biotechnology - Intellectual Property Researchers Europe (IPRE) Conference, organized by the World Intellectual Property Organization (WIPO), and the World Trade Organization (WTO), and the School of Law, University of Geneva (UNIGE), Geneva

Technology Transfer and Licensing in Practice, WHO-WIPO-WTO – 4th Trilateral Webinar, hosted from WTO Headquarters, Geneva, YouTube video 

Publication of Contribution of the Committee on International Trade Law, in To the Benefit of International Law, eds. C. Kessedjian, O. Descamps & T. Fabrizi, Editions Pantheon-Assas (2023)

 Prosecuting Excessive Pricing of Pharmaceuticals under Competition Law: Evolutionary Development,24 Columbia Science & Technology Law Review 173 (2023)

 Reflections on Four Sets of Challenges: Navigating the Path Forward in Improving Access with Collective Action after the WLPF, WHO Local Production and Assistance (LPA) Unit Panel, 12th Annual Investment Meeting, Abu Dhabi, UAE

Participate as member of WHO C-TAP Technical Advisory Group (TAG) in meeting of TAG at WHO Headquarters, Geneva

The World Keeps Turning: IP Rules for the Age of Deglobalization, at Creativity and Innovation Is Local Symposium, Texas A&M Law (Ft. Worth, Texas)

Presentation on IP Licensing for the Local Production of Medicines, 2nd Intellectual Property for Health Seminar for Health Attachés, WIPO headquarters, Geneva (hybrid – online)

Published, A competition law approach to accessing insulin: A working paper, authored by Frederick M. Abbott and Padmashree Gehl Sampath, United Nations Development Programme (2022)

Presentation on Enhancing technology access and technology transfer for domestic manufacturing in Africa, Launch Event for the African Pharmaceutical Technology Foundation, Kigali, Rwanda (in-person)

Presentation on Exhaustion of copyright in the context of crossborder uses of research materials, Global Expert Network on Copyright User Rights, Geneva, Switzerland (in-person)

Excessive pricing doctrine in the pharmaceutical sector: from theory to cost accounting, South African Competition Authority

Presentation on 100 Years of International IP - Reflections on Past, Present and Future, Centennial Meeting of American Branch of the International Law Association (ABILA), New York City 

Presentation on Responding to the Wave of Cybercrime, WIPO Domain Name Panelists Meeting, Geneva

Presentation on Regionalizing Pharmaceutical Production and Innovation, Panel on Social Protection and Health: South-South and Triangular Cooperation to Enhance Capacity to Produce and Deliver Vaccines, Thematic Solution Forum 7, Global South-South Development Expo 2022 Bangkok (hybrid meeting, presentation remote)

Chaired panel on Global Health Law in a Deteriorating Environment and Co-Chaired Open Session of Global Health Law Committee at the International Law Association 80th Biennial Conference in Lisbon, Portugal

Excessive pricing doctrine in the pharmaceutical sector: from theory to cost accounting, Italian Competition Authority

Presentation, Using Competition Law to Promote Access to Health Technologies: the UNDP Guidebook: A discussion on the new edition of the UNDP Guidebook on competition law and pharmaceuticals, Syracuse Univ. College of Law 

Publication of Using Competition Law to Promote Access to Health Technologies: A Supplement to the Guidebook for Low- and Middle-Income Countries (UNDP), authored by Frederick M. Abbott

Statement condemning Russia's aggression against Ukraine by members of Global Health Law Committee of the International Law Association (F. M. Abbott, co-Chair); ILA Statement on the Ongoing and Evolving Aggression In and Against Ukraine, March 3, 2022

International Law Association, 2022 Report, Global Health Law, draft text of February 22, 2022, Fourth Report of the Committee

 Technology Governance in a Devolved Global Legal Order: Lessons from the China-USA Strategic Conflict, in A New Global Economic Order, pgs. 197-226, Chia-Jui Cheng ed. (Brill/Nijhoff) (2022)

China's Legal Integration with the Global Intellectual Property System and the Road Ahead, Conference on 20th Anniversary of China's Accession to the WTO, Peking University Law School, Beijing, China (hybrid online and in-person)

Global Governance and World Health Organization Reform in the Wake of COVID-19, International Law Weekend, American Branch of the International Law Association (ABILA)

Presentation, The COVID-19 Technology Transfer Environment and the Potential Uses of WIPO’s New ADR Options, Online Workshop on New WIPO ADR Options for Life Sciences, WIPO’s COVID-19 Related Services and Support, (Geneva) Online

Keynote presentation, Trends in the Development and Use of Competition Law to Promote Access to the Benefits of Health Technologies, A Dialogue: Trends and Strategies in the Use of Competition Law to Promote Innovation of and Affordable Access to Health Technologies, UNDP in cooperation with the Government of Namibia and the Namibia Competition Commission, Online

The Work Program of the Global Health Committee in an Era of Unprecedented Challenges, The COVID-19 Pandemic and International Law, German Association of International Law, Working Group: International Health Law & Max Planck Institute for Comparative Public Law and International Law 

Keynote Address, Excessive pricing doctrine in the pharmaceutical sector: past, present and future, EU Competition Law and Pharmaceuticals Workshop, hosted by the Netherlands Authority for Consumers and Markets (ACM) 

Speaker at International Seminar on “Harnessing Public Research for Innovation in the Time of COVID-19 and Beyond – The Role of Knowledge Transfer Policies”, organized by the World Intellectual Property Organization (WIPO), in cooperation with AUTM, ICC and LESI, Geneva (online)

Appointed to the Technical Advisory Group (TAG) on the World Health Organization COVID-19 Technology Access Pool (2-year term)

Panelist presentation at first WHO World Local Production Forum, Session 4, Expanding Access to Affordable Capital, Geneva (online)

 Localization of Pharmaceutical Production and the Dissemination of Health Technologies, World Trade Organization, 2021 Trade and Public Health Virtual Course Webinar: Dissemination of Health Technologies, YouTube link: https://youtu.be/Sx4KottMKAY

 Using Competition Law to Promote Affordable Access to Health Technologies in Low-and Middle-Income Countries, Fair Pricing in times of public health emergency and to accelerate achievements of Sustainable Development Goals health targets, World Health Organization 2021 Fair Pricing Forum, organized with the support of Argentina

F. Abbott, R. Abbott, J. Fortunak, P. Gehl Sampath & D. Walwyn, Opportunities, Constraints and Critical Supports for Achieving Sustainable Local Pharmaceutical Manufacturing in Africa: With a Focus on the Role of Finance, Final Report, March 18, 2021 (Nova Worldwide), also available at https://nova-worldwide.com/OSF-PHP_report (with Executive Summary and Addenda); DOI: 10.33009/osf-php_report; DOI link: https://doi.org/10.33009/osf-php_report

 Child-Proofing Global Public Health in Anticipation of Emergency, project on Global Governance: The World Health Organization (WHO) and the Need for Post-COVID-19 Reform collection in Washington University Global Studies Law Review (forthcoming 2021)

Facilitating Access to Cross-Border Supplies of Patented Pharmaceuticals: The Case of the COVID-19 Pandemic (co-author with Jerome H. Reichman), Journal of International Economic Law (Oxford)(Volume 23, Issue 3, pp. 535-561, Sept. 2020)

 The TRIPS Agreement Article 73 Security Exceptions and the COVID-19 Pandemic, Research Paper 116, South Centre, Geneva (August 2020)

World Trade Organization Faces Leadership Battle In Shadow Of Crisis Over Organization’s Future, Health Policy Watch; Confronting COVID-19 In A World Without WHO – Seriously?, Health Policy Watch, April 14, 2020 

International Experiences and Access to Medicines: Synthesizing Trends and Reflecting on Paths Forward, Presentation at Fair and Equitable Pricing in Health: Competition Law and Access to Medicines, South Centre/IDEC Webinar

Do Trade Rules on Intellectual Property Represent an Obstacle to Global Access to a Coronavirus Vaccine?, Presentation at Queen’s Institute on Trade Policy 2020, Trade Rules for the Pandemic and Its Aftermath

Presentation at WHO Workshop - Understanding patents and other intellectual property relevant to local production

Webinar with Frederick Abbott and Gian Luca Burci, et al, COVID-19 and International Law: A Snapshot, a CLE seminar hosted on April 28, 2020, by the Bar Association of Metropolitan St. Louis, Whitney R. Harris World Law Institute at Washington University in St. Louis School of Law, and the International Law Association (American Branch

Article: Under the Radar: Reflections on ‘Forced’ Technology Transfer and the Erosion of Developmental Sovereignty in GRUR International (Oxford), Issue 3 (planned),

Presentation on Pharmaceuticals, Market Exclusivities and Abuse of Dominance: The Evolution of Excessive Pricing Doctrine, How much is too much? at Excessive Pharmaceutical Prices in European Competition Law & Regulation, CeBIL, Copenhagen University

Presentation on Law and its limitations in global public health: Non-voluntary patent licensing post-Doha at Innovation, Justice, and Globalization – A Celebration of J.H. Reichman • Harvard Law School, Harvard University

Presentation on TRIPS, Strategic Competition and Global Welfare: IP at the Intersection of Law and Power at Conference on A Changing International Economic Order and the Response from International Law, at University of International Business and Economics (UIBE), Beijing, China

Presentation on Health Technologies, Market Exclusivities and Abuse of Dominance: Methodology and Structure for Competition Law Enforcement, at IP Researchers Europe Conference. organized by the World Intellectual Property Organization (WIPO), the World Trade Organization (WTO) and the School of Law, University of Geneva (UNIGE), Geneva,

Presentation on Technology Transfer and Development, Distinguished Honorary Panel, CEIPI/WIPO/INPI Advanced Training Course, Strasbourg

Working Paper, TRIPS, Strategic Competition and Global Welfare: IP at the Intersection of Law and Power, Presented at Symposium on the TRIPS Agreement at 25, Texas A&M Law School, Fort Worth, Texas

In Memoriam: Dilip Shah (1941-2019), Intellectual Property Watch

Using competition law to address high medicines prices: Webinar, with accompanying PowerPoint, Global Health Centre – Graduate Institute|Geneva

Presentations on IP, Trade and Development and IP and Health at Summit on Global Trade, Technology Innovation, Intellectual Property and Development, WTO and China Academy of International Trade and Economic Cooperation, with WIPO, Xiamen, Fujian, China

Developments and Trends in Competition Law and Practice, 5th Global Congress on Intellectual Property and the Public Interest, Washington, DC

Report on Activities at International Law Association Sydney Biennial

The UK Competition Appeal Tribunal’s Misguided Reprieve for Pfizer’s Excessive Pricing Abuse, in IIC - International Review of Intellectual Property and Competition Law, Volume 49

Excessive Pricing and Sham Patent Litigation: The Pfizer and AbbVie Decisions, Intellectual Property Watch

Report of the Global Health Law Committee of the International Law Association prepared for the 2018 Sydney Biennial Conference

Technology Governance in a Devolved Global Legal Order: lessons from the China-USA strategic conflict in A New Global Economic Order, Cheng Chia-Jui, et al, eds. (Brill/Nijhoff Publishers) 

US Section 301, China, and technology transfer: Law and its limitations revisited (again), International Center for Trade and Sustainable Development (ICTSD), Opinion,

Reflection Paper on China in the World Trading System: Defining the Principles of Engagement in CHINA IN THE WORLD TRADING SYSTEM: DEFINING THE PRINCIPLES OF ENGAGEMENT, pp. 1-43, F.M. Abbott, ed.

Technology and State Enterprise in the WTO in STATE TRADING IN THE TWENTY-FIRST CENTURY 121, T. Cottier and P. Mavroidis, eds., U. Mich

China in the WTO 2006: 'Law and its Limitations' in the Context of TRIPS in WTO LAW AND DEVELOPING COUNTRIES, pp. 59-81, G. Bermann, P. Mavroidis, eds., Cambridge Univ

China Policies to Promote Local Production of Pharmaceutical Products and Protect Public Health, Published by: Geneva

Excessive Pharmaceutical Prices and Competition Law: Doctrinal Development to Protect Public Health, forthcoming in UC Irvine Law Review, Volume 6, Issue 3, Spring 2017

Rethinking Patents: From ‘Intellectual Property’ to ‘Private Taxation Scheme’, in KRITIKA: ESSAYS ON INTELLECTUAL PROPERTY, vol. 1, pgs. 1-16 (eds. P. Drahos, G. Ghidini, H. Ullrich), Edward Elgar 2015

Trade in medines, in Trade and Health: Towards building a National Strategy 117-40 (eds. R. Smith et al.), World Health Organization (2015)

Third Contribution to Roundtable on Climate mitigation and intellectual property in tension, Let a thousand technologies bloom (Bulletin of the Atomic Scientists, Mar. 13, 2015)

Second Contribution to Roundtable on Climate mitigation and intellectual property in tension, Aggregating capital, addressing climate change (Bulletin of the Atomic Scientists, Mar. 13, 2015)

Summary Report of Global Health Security Meeting, ILA Global Health Law Committee - Graduate Institute|Geneva Global Health Programme, Feb. 19, 2015

Contribution to Roundtable on Climate mitigation and intellectual property in tension, A problem, but not without solutions (Bulletin of the Atomic Scientists, Feb. 19, 2015)

Recent Presentation: Groundhog Day: Health-related provisions in FTAs and TRIPS (ICTSD Dialogue, Oct. 30, 2014)

Recent Presentation: Transfer of Technology and a Global Clean Energy Grid (World Trade Forum, Sept. 27, 2014)

Articles and Studies: The LDC Medicines Extension Question: Contemplating next steps (Bridges Africa, Sept. 2014)

IP-Watch Inside Views Contribution on competition/antitrust decisions on excessive pricing and sham patent litigation

Editorial on approach to international competition negotiations publiched in IIC

Presentations at ISAGS-UNISUR / Fiocruz / UNDP Consultation on Competition and Access to Health Technologies 

Comment on US Supreme Court decision adopting and affirming international exhaustion of patents published in IIC

Presentations at DTI South Africa - Workshop on Draft Intellectual Property Policy, Policy Coherence, IP and Competition, Compulsory Licensing and Government Use

Presentation (PPT and Audio), A Never-ending Tale: IP governance, the (captured) regulatory state and the world of second bests, Conference in Honour of Pedro Roffe, Geneva

IP-Watch, Inside Views: US Supreme Court Adopts International Exhaustion of Patents (Part II): Addressing the New Competitive Landscape

IP-Watch,Inside Views: US Supreme Court Adopts International Exhaustion for Patents: Paving the way for parallel imports to exert downward pressure on domestic pharmaceutical (and other) prices

Presentation (PPT and Audio), Competition Doctrines for the Medicines Sector: Innovation and Affordability, 7th ASEAN Competition Conference 2017 - ASEAN@50  – Managing Change in a Competitive ASEAN, March 8, 2017. Kuala Lumpur, Malaysia

Presentation (PPT) on Non-Voluntary Patent Licensing in International Law at Workshop on the History, Experiences, and Prospects of Compulsory Licensing of Medical Patents in the United States, KEI – February 24, 2017, Washington, DC

Presentation (audio) at WTO@20 Conference, New Delhi - The WTO and Intellectual Property in the Midst of Tectonic Shift

Amicus Brief to Supreme Court filed January 20, 2017 in Impression Products v. Lexmark International (International Exhaustion of Patents)

Lecture on Trade and Economic Impact of Trump Election, Nov. 9, 2016

Presentations at South Africa Department of Trade and Industry, UNDP, UNCTAD Public Consultation on Intellectual Property Policy
 

Meeting of ILA Global Health Law Committee

No dispute on public health, The Hindu BusinessLine, July 22, 2016 (Uruguay ISDS tobacco case)

Initiation of Pharmaceutical Sector Inquiry in Indonesia

Presentation at Official BRICS Side Event, 69th World Health Assembly, Geneva, May 23, 2016, TRIPS plus provisions in plurilateral/regional trade agreements and their impact on access to medicines at the national and global level 

Submission to Senate Finance Committee on March 3, 2016 in response to request feedback regarding the report on “The Price of Sovaldi and its impact on the U.S. Health Care System”

Global Health Law Committee submissions to UN High Level Panel on Access to Medicines process to be presented in London on

Peter Gosselin, Obama Pushes Trade Partners to Add Drug Rules He Opposes in U.S., Washington Post/Bloomberg News

Soumonty Kanungo, Biased? India has a balanced pharma patent regime, DNA India

Anju Ghangurde, Prof Abbott on Lilly's 'borderline absurd' ISDS plaint and the TPP, SCRIP Intelligence

Bridging Innovations: Technology Transfer for Sustainable Local Production, The Road to World Local Production Forum 2025, World Health Organization, AIM Congress 2024 (Adapting To A Shifting Investment Landscape: Harnessing New Potential For Global Economic Development), Abu Dhabi --- At bottom

May 21, 2014 William New interviews Frederick Abbott

Discussing Emerging Markets and the World Patent Order

Link to text